';

Stephen Osborne PhD

Stephen Osborne PhD

Research Director

Areas of Expertise
  • Proteomics, Molecular Biology, Molecular and Immunodiagnostics
  • Team and Project Management
  • New Technology Development
Stephen Osborne has over 25 years of biotechnology development expertise with specialisation in proteomics, molecular and immunodiagnostics.

He has also spent a number of years working as a stockbroker advising on investment opportunities in healthcare and biotechnology companies and aiding fundraising activities for the aforementioned companies, from start-ups to those quoted on UK and European exchanges.

Stephen has a BSc. In Biotechnology and a PhD in Biochemical Engineering. Following his academic training he has worked extensively in the in-vitro diagnostics industry of which much time was spent in Italy where he ultimately ran the R&D group for a major European diagnostic manufacturer (Mkt Cap euro 2.9bn). Of particular interest is the integration of different specialities (biology, chemistry, electrical and mechanical engineering, optics etc.).

Stephen is also the CEO of Pastel BioScience, a start-up company founded by himself which is developing novel next-generation proteomics technologies for the discovery of protein based biomarkers and their subsequent application to drug discovery and diagnostics.

Contact

Contact

Contact